. Author manuscript; available in PMC: 2017 Jul 26.

Published in final edited form as: J Diabetes Complications. 2016 May 10;30(7):1401–1407. doi: 10.1016/j.jdiacomp.2016.05.007

Table 1.

Response-to-therapy rates based on number of EFNS/PNS criteria met.

EFNS/PNS criteria	Treatment responders % (n)

	Whole cohort	CIDP without DM	CIDP with DM
0	30 (8/27)	31 (5/16)	27 (3/11)
1	53 (20/38)	58 (14/24)	43 (6/14)
2	72 (13/18)	67 (8/12)	83 (5/6)
3	78 (7/9)	67 (4/6)	100 (3/3)
4	71 (5/7)	71 (5/7)	–
OR^* (CI)	1.83 (1.22, 2.74)	1.53 (0.99, 2.36)	3.73 (1.32, 10.60)
P	0.003	0.05	0.01

Table adapted from Abraham A et al. Expert Rev Clin Immunol 2015;11(4):537–546 with permission.

^**

Odds ratio calculated by logistic regression with treatment responder (yes or no) as the dependent variable. CI, confidence interval; CIDP, chronic inflammatory demyelinating polyneuropathy; DM, diabetes mellitus; EFNS/PNS, European Federation of Neurological Societies/Peripheral Nerve Society; OR, odds ratio.